Literature DB >> 6932531

Depression of murine macrophage accumulation by low-molecular-weight derived from spontaneous mammary carcinomas.

G J Cianciolo, R B Herberman, R Snyderman.   

Abstract

Extracts prepared from spontaneous mouse mammary adenocarcinomas, as well as plasma and urine from inbred C3H/HeN mice carrying murine mammary tumor virus and bearing such tumors, significantly inhibited the accumulation of macrophages at inflammatory sites in inbred the accumulation of macrophages at inflammatory sites in inbred C3Heb/FeJ mice. Much of the inhibitory activity from tumor cells was associated with products having a molecular weight (¿ 30,000); the inhibitory factor isolated from the plasma and urine of tumor-bearing animals had a molecular weight of 30,000 or less. Liver and spleen tissue, plasma, and urine from non-tumor-bearing animals had a molecular weight of 30,000 or less. Liver and spleen tissue, plasma, and urine from non-tumor-bearing animals had no effect on macrophage accumulation. Tumor cell extracts, plasma, and urine from tumor-bearing mice were shown to be free of infectious lactate dehydrogenase virus, a frequent contaminant of transplanted tumor and a known modifier of macrophage function. These results agreed with earlier reports of inhibitory activity for macrophage accumulation found in the tumors and sera of mice bearing multiple-passaged transplanted tumors and suggested that spontaneously arising neoplasms may subvert immune surveillance by depressing the ability of macrophages to respond to inflammatory stimuli.

Entities:  

Mesh:

Year:  1980        PMID: 6932531     DOI: 10.1093/jnci/65.4.829

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  12 in total

Review 1.  Feline leukemia virus: current status of the feline induced immune depression and immunoprevention.

Authors:  R G Olsen; M G Lewis; L J Lafrado; L E Mathes; K Haffer; R Sharpee
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 2.  Macrophage infiltration and tumor progression.

Authors:  S J Normann
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

3.  Immunosuppressive retroviral-related factors in sera of patients with head and neck cancer.

Authors:  I B Tan; A J Balm; G B Snow; H A Drexhage
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

4.  Macrophage and dendritic cell infiltration in head and neck squamous-cell carcinoma; an immunohistochemical study.

Authors:  J D Kerrebijn; A J Balm; P P Knegt; C A Meeuwis; H A Drexhage
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

5.  Effects of soluble mediators generated during growth of the Landschütz ascites carcinoma on the chemotaxis of normal and Corynebacterium parvum-stimulated peritoneal leucocytes.

Authors:  L C McIntosh; A W Thomson
Journal:  Br J Exp Pathol       Date:  1984-08

Review 6.  Effects of tumor growth on host defenses.

Authors:  G J Cianciolo; R Snyderman
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

7.  The presence of immunosuppressive 'p15E-like' factors in the serum and urine of patients suffering from malign and benign breast tumours.

Authors:  H Stöger; M Wilders-Truschnig; H Samonigg; M Schmid; T Bauernhofer; A Tiran; M Tas; H A Drexhage
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

8.  Anti-inflammatory and vasoprotective activity of a retroviral-derived peptide, homologous to human endogenous retroviruses: endothelial cell effects.

Authors:  George J Cianciolo; Salvatore V Pizzo
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

9.  Suppression of macrophage oxidative metabolism by products of malignant and nonmalignant cells.

Authors:  A Szuro-Sudol; C F Nathan
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

10.  Human malignant and mitogen-transformed cells contain retroviral P15E-related antigen.

Authors:  G J Cianciolo; D Phipps; R Snyderman
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.